MDP is undervalued and that puzzles meDid some more research and looked closely at the numbers. I'm puzzled why this is a $7 to $8 stock it should be at the least $12. Way undervalued. Revenue growth was huge 31.5M last quarter which would mean $12/shr value.
I'm adding more because the real story isn't the Nasdaq listing, it is the sales growth for next quarter and so on. If next quarter numbers come out and they are as good as last quarter or better then the stock should be $15/shr. In my opion this stock is a strong buy. GLTA